| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 273,447 | 262,174 | 238,771 | 275,673 | | Cost of Revenue | 224,066 | 238,553 | 218,523 | 252,262 | | | Gross Profit | 49,381 | 23,621 | 20,248 | 23,411 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,998 | 20,514 | 19,031 | 23,422 | | Non Recurring | 1,047 | 3,101 | 789 | 490 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,336 | 6 | 428 | (501) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30 | (1) | 66 | 97 | | Earnings Before Interest And Taxes | 26,366 | 5 | 494 | (404) | | Interest Expense | 2,443 | 3,069 | 2,659 | 2,600 | | Income Before Tax | 23,923 | (3,064) | (2,165) | (3,004) | | Income Tax Expense | 9,282 | (1,149) | (812) | (1,227) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,641 | (1,915) | (1,353) | (1,777) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,641 | (1,915) | (1,353) | (1,777) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,641 | ($1,915) | ($1,353) | ($1,777) |
|
0.20% Nasdaq 
0.38%
Income Statement
